B cell-tailored dosing of ocrelizumab shows good results Presented ByMs Laura Hogenboom, Amsterdam University Medical Center, the Netherlands TrialBLOOMS ConferenceECTRIMS 2024 TypePeer-reviewed article 18 November 2024 12:28